SG3 Management, LLC - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 206 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.52 and the average weighting 0.1%.

Quarter-by-quarter ownership
SG3 Management, LLC ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$129,000
-93.6%
6,500
-93.6%
0.00%
-95.0%
Q3 2021$2,010,000
-72.8%
102,100
-69.6%
0.06%
-77.1%
Q2 2021$7,394,000
+60.3%
336,100
+73.4%
0.26%
+127.8%
Q1 2021$4,612,000
+171.1%
193,828
+198.2%
0.12%
+248.5%
Q4 2020$1,701,000
+179.3%
65,000
+85.7%
0.03%
+50.0%
Q3 2020$609,00035,0000.02%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,003,723$95,164,0006.41%
TANAKA CAPITAL MANAGEMENT INC 65,609$780,0003.41%
S&T BANK/PA 588,620$6,999,0001.93%
Parallel Advisors, LLC 1,405,895$16,716,0001.35%
Matarin Capital Management, LLC 623,915$7,418,0001.15%
AJ WEALTH STRATEGIES, LLC 668,020$7,943,0001.08%
Capital Impact Advisors, LLC 177,300$2,108,0000.88%
Alambic Investment Management, L.P. 29,547$351,0000.85%
OXFORD FINANCIAL GROUP, LTD. LLC 332,436$3,953,0000.79%
Spark Investment Management LLC 116,400$1,383,0000.74%
View complete list of CORCEPT THERAPEUTICS INC shareholders